Suppr超能文献

三联合手术(白内障超声乳化吸除联合玻璃体切除并后囊切开术)与白内障超声乳化吸除联合玻璃体切除序贯手术的成本效益比较。

Cost-effectiveness of the triple procedure - phacovitrectomy with posterior capsulotomy compared to phacovitrectomy and sequential procedures.

机构信息

Department of Ophthalmology, Oslo University Hospital and University of Oslo, Oslo, Norway.

Faculty of Dentistry, University of Oslo, Oslo, Norway.

出版信息

Acta Ophthalmol. 2020 Sep;98(6):592-602. doi: 10.1111/aos.14367. Epub 2020 Feb 20.

Abstract

PURPOSE

To evaluate the cost-effectiveness of the triple procedure (phacovitrectomy + posterior capsulotomy, PhacoPPVc) compared to the double- (phacovitrectomy, PhacoPPV) or single sequential procedures.

METHODS

Prospective study on 31 eyes from 31 patients (mean age: 72.1 ± 9.1 years; 55% females) was performed with a preoperative decision to undergo only pars plana vitrectomy (PPV) (26%) or PhacoPPV (74%) and/or posterior capsulotomy based upon presence or absence of lens opacification or pseudophakia. Time during and between surgeries, surgical procedure codes, medical and transport costs, outcome and likelihood of complications after surgery were all included in the analysis. Societal perspectives and visual acuity were considered as measures of quality of adjusted life years (QALYs).

RESULTS

About 23 eyes underwent triple procedure and eight eyes underwent vitrectomy only (mean surgery times: 35.9 and 24.0 min, respectively). Posterior capsulotomy took on average 30 s, while preparation and cataract procedure took 13.0 min. The patients travelled on average 80km (average cost: $280.12) to the surgery unit. The average reimbursement fee for the day procedures ranged between $174.17 (YAG capsulotomy; Diagnosis Related Group (DRG): 0.034), $1045.48 (Phaco + intraocular lens (IOL); DRG: 0.204) and $1701.32 (PPV; DRG: 0.332). The combined procedures excluded lens and laser reimbursements, while the calculated reimbursements for the double/triple procedures were $2713.08/$2901.45, respectively, without significant loss of QALYs. PhacoPPVc was found to be unequivocally cost-effective, while PhacoPPV remained cost saving compared to sequential procedures.

CONCLUSION

This study confirms that the triple procedure has benefits to the patients, health institution and surgeon. For patients, it saves them travel and healing time; for health institution, it justifies the calculated higher costs and need for higher reimbursement for the double/triple procedures, which are cost saving.

摘要

目的

评估三联手术(超声乳化玻璃体切除术+后囊切开术,PhacoPPVc)与双(超声乳化玻璃体切除术,PhacoPPV)或单序贯手术相比的成本效益。

方法

对 31 名患者的 31 只眼进行前瞻性研究(平均年龄:72.1±9.1 岁;55%为女性),术前决定仅行玻璃体切除术(PPV)(26%)或行超声乳化玻璃体切除术+人工晶状体植入术(PhacoPPV)(74%),并根据晶状体混浊或无晶状体的存在与否决定是否行后囊切开术。分析术中及术间时间、手术程序代码、医疗和交通费用、手术结果和术后并发症发生的可能性。社会视角和视力被视为调整生命年(QALYs)质量的衡量标准。

结果

约 23 只眼行三联手术,8 只眼仅行玻璃体切除术(平均手术时间分别为 35.9 和 24.0 分钟)。后囊切开术平均耗时 30 秒,而准备和白内障手术耗时 13.0 分钟。患者平均旅行 80 公里(平均费用:280.12 美元)到手术单位。日间手术的平均报销费用在 174.17 美元(YAG 后囊切开术;诊断相关组(DRG):0.034)、1045.48 美元(Phaco+人工晶状体(IOL);DRG:0.204)和 1701.32 美元(PPV;DRG:0.332)之间。联合手术不包括晶状体和激光报销,而双/三联手术的计算报销费用分别为 2713.08 美元/2901.45 美元,同时并未显著损失 QALYs。PhacoPPVc 被证明具有明确的成本效益,而 PhacoPPV 与序贯手术相比仍具有成本节约性。

结论

本研究证实,三联手术对患者、医疗机构和外科医生均有益处。对患者而言,它节省了他们的旅行和康复时间;对医疗机构而言,它证明了计算出的双/三联手术更高的成本和更高的报销费用是合理的,因为这是具有成本节约性的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验